AZN
AstraZeneca PLC
$77.50
+$1.22(+1.60%)
85
Overall
80
Value
90
Tech
--
Quality
Market Cap
$240.75B
Volume
4.87M
52W Range
$61.24 - $82.41
Target Price
$85.09
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $24.7B | $23.0B | $22.5B | $22.1B | $24.4B | $26.6B | $37.4B | $44.4B | $45.8B | $54.1B | ||
| Total Revenue | $24.7B | $23.0B | $22.5B | $22.1B | $24.4B | $26.6B | $37.4B | $44.4B | $45.8B | $54.1B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $4.6B | $4.1B | $4.3B | $4.9B | $4.9B | $5.3B | $12.4B | $12.4B | $8.3B | $10.2B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $20.1B | $18.9B | $18.1B | $17.2B | $19.5B | $21.3B | $25.0B | $32.0B | $37.5B | $43.9B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $17.0B | $15.3B | $15.4B | $16.6B | $18.8B | $17.4B | $25.1B | $28.7B | $28.8B | $34.1B | ||
| Research & Development | $6.0B | $5.9B | $5.8B | $5.9B | $6.1B | $6.2B | $10.3B | $9.8B | $10.9B | $13.6B | ||
| Research Expense | -- | -- | -- | -- | -- | -- | -- | $9.8B | $10.9B | -- | ||
| Selling, General & Administrative | $11.5B | $9.7B | $9.9B | $11.0B | $13.0B | $11.9B | $15.6B | $19.0B | $19.8B | $20.5B | ||
| Selling & Marketing Expenses | $11.5B | $9.7B | $9.9B | $11.0B | $13.0B | $11.9B | $15.6B | $19.0B | $19.8B | $20.5B | ||
| General & Administrative Expenses | $11.1B | $9.4B | $10.2B | -- | -- | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | $114.0M | $86.0M | $45.0M | $4.0M | $4.0M | $2.0M | $1.0M | -- | -- | -- | ||
| Depreciation & Amortization | $-716.0M | $-590.0M | $-1.1B | $-1.7B | $-1.6B | $-797.0M | $-2.2B | -- | -- | -- | ||
| Amortization | $114.0M | $86.0M | $45.0M | $4.0M | $4.0M | $2.0M | $1.0M | -- | -- | -- | ||
| Other Operating Expenses | $17.0M | $141.0M | $168.0M | $93.0M | $108.0M | $68.0M | $308.0M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $3.1B | $3.6B | $2.7B | $516.0M | $690.0M | $3.9B | $-134.0M | $3.2B | $8.7B | $9.8B | ||
| EBITDA | $4.1B | $4.9B | $3.6B | $3.4B | $3.0B | $8.1B | $5.1B | $9.1B | $13.9B | $17.1B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $1.0B | $1.4B | $1.4B | $1.4B | $1.4B | $1.3B | $1.3B | $1.3B | $1.6B | $1.7B | ||
| Intinc | $36.0M | $59.0M | $109.0M | $138.0M | $165.0M | $83.0M | $43.0M | $81.0M | $301.0M | $345.0M | ||
| Net Non-Operating Interest Income/Expense | $1.0B | $1.3B | $1.3B | $1.2B | $1.2B | $1.2B | $1.2B | $-1.2B | $-1.3B | $-1.3B | ||
| Other Income/Expense | -- | -- | -- | -- | -- | -- | -- | $-923.0M | $-1.4B | $-319.0M | ||
| Other Special Charges | -- | -- | -- | -- | -- | -- | -- | $698.0M | $1.0B | $252.0M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-378.0M | -- | $208.0M | $-514.0M | $-574.0M | $-194.0M | $47.0M | -- | -- | -- | ||
| Special Income Charges | $-1.0B | $-1.3B | $-1.0B | $-3.0B | $-2.4B | $-1.2B | $-1.2B | -- | -- | -- | ||
| Impairment of Capital Assets | $64.0M | -- | $78.0M | -- | -- | $12.0M | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $4.1B | $4.9B | $3.6B | $3.4B | $3.0B | $5.2B | $1.0B | $4.2B | $8.5B | $10.4B | ||
| Pre-Tax Income | $3.1B | $3.6B | $2.2B | $2.0B | $1.5B | $3.9B | $-265.0M | $2.9B | $6.9B | $8.7B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $243.0M | $146.0M | $-641.0M | $-57.0M | $321.0M | $772.0M | $-380.0M | $792.0M | $938.0M | $1.6B | ||
| NET INCOME | ||||||||||||
| Net Income | $2.8B | $3.5B | $3.0B | $2.2B | $1.3B | $3.2B | $112.0M | $2.1B | $6.0B | $7.0B | ||
| Net Income (Continuing Operations) | $2.8B | $3.4B | $2.9B | $2.0B | $1.2B | $3.1B | $115.0M | $2.1B | $6.0B | $7.0B | ||
| Net Income (Discontinued Operations) | $2.8B | $3.5B | $3.0B | $2.2B | $1.3B | $3.2B | $112.0M | $2.1B | $6.0B | $7.0B | ||
| Net Income (Common Stockholders) | $2.8B | $3.5B | $3.0B | $2.2B | $1.3B | $3.2B | $112.0M | $2.1B | $6.0B | $7.0B | ||
| Normalized Income | $1.4B | $1.5B | $571.0M | $-1.0B | $-1.2B | $1.9B | $-1.8B | $2.1B | $4.9B | $8.6B | ||
| TOTALS | ||||||||||||
| Total Expenses | $-21.6B | $-19.4B | $-19.8B | $-21.6B | $-23.7B | $-22.7B | $-37.6B | $41.1B | $37.1B | $44.3B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.4B | $1.5B | $1.5B | -- | ||
| Average Shares Outstanding (Diluted) | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.4B | $1.6B | $1.6B | -- | ||
| Shares Outstanding | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.5B | $1.3B | $3.1B | $3.1B | ||
| Basic EPS | $2.23 | $2.77 | $2.37 | $1.7 | $1.03 | $2.44 | $0.08 | $2.12 | $3.84 | -- | ||
| Basic EPS (Continuing Operations) | $2.23 | $2.77 | $2.37 | $1.7 | $1.03 | $2.44 | $0.08 | $2.12 | $3.84 | -- | ||
| Diluted EPS | $2.23 | $2.76 | $2.37 | $1.7 | $1.03 | $2.44 | $0.08 | $2.11 | $3.81 | -- | ||
| Diluted EPS (Continuing Operations) | $2.23 | $2.76 | $2.37 | $1.7 | $1.03 | $2.44 | $0.08 | $2.11 | $3.81 | -- | ||
| Dividend Per Share | $2.82 | $2.71 | $2.76 | $2.75 | $2.83 | $2.81 | $2.8 | $2.9 | $2.9 | -- | ||
| OTHER METRICS | ||||||||||||
| Earnings from equity interest | -- | -- | -- | -- | -- | -- | -- | $-5.0M | $-12.0M | $-28.0M | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | -- | -- | -- | -- | -- | $-5.0M | $-12.0M | $-28.0M | ||
| Gain On Sale Of P P E | -- | -- | -- | -- | -- | -- | -- | $216.0M | $292.0M | -- | ||
| Minority Interests | $1.0M | $-93.0M | $-133.0M | $-105.0M | $-108.0M | $52.0M | $-3.0M | $-5.0M | $-6.0M | $-6.0M | ||
| Other Costof Revenue | -- | -- | -- | -- | -- | -- | -- | $12.4B | $8.3B | $10.2B | ||
| Other Gand A | $11.1B | $9.4B | $10.2B | -- | -- | -- | -- | -- | -- | -- | ||
| Othspecchg | $-733.0M | $-1.3B | $-1.3B | $-2.5B | $-1.8B | $-1.1B | $-1.2B | -- | -- | -- | ||
| Restruct | $-378.0M | -- | $208.0M | $-514.0M | $-574.0M | $-194.0M | $47.0M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AZN | $77.50 | +1.6% | 4.87M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |